← Mechanisms of action
GBA
SINGLE PROTEINHomo sapiens
Preferred name: Beta-glucocerebrosidase ChEMBL ↗
Linked proteins
Drugs acting on this target (12)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| beta glucosylceramide | Activator | experimental | Small molecule | GBA activator |
| bia 28-6156 | Activator | experimental | Small molecule | GBA activator |
| afegostat tartrate | Stabiliser | experimental | Small molecule | GBA stabiliser |
| avr-rd-02 | Supplementation | experimental | Cell therapy | GBA supplementation |
| can103 | Supplementation | experimental | Recombinant protein | GBA supplementation |
| flt201 | Supplementation | experimental | Gene therapy | GBA supplementation |
| glucocerebrosidase (lysodase) | Supplementation | experimental | Recombinant protein | GBA supplementation |
| human glucocerebrosidase cdna | Supplementation | experimental | Gene therapy | GBA supplementation |
| imiglucerase (cerezyme) | Supplementation | approved | Recombinant protein | GBA supplementation |
| prx-112 | Supplementation | experimental | Recombinant protein | GBA supplementation |
| taliglucerase alfa (elelyso) | Supplementation | approved | Recombinant protein | GBA supplementation |
| vgn-r08b | Supplementation | experimental | Gene therapy | GBA supplementation |